DexCom Inc

DXCM.US
Healthcare · Medical Devices
74.85
+1.48 (+2.02%)
USD · NASDAQ

Company Information

Company Name
DexCom Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US2521311074
CIK: 0001093557
CUSIP: 252131107
Currency: USD
Full Time Employees: 11,000
Phone: 858 200 0200
Fiscal Year End: December
IPO Date: Apr 14, 2005
Description:

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Address:

6340 Sequence Drive, San Diego, CA, United States, 92121

People

Directors & Officers

Name Title Year Born
Mr. Kevin Ronald Sayer Executive Chairman of the Board 1958
Mr. Jacob Steven Leach President, CEO & Director 1978
Mr. Jereme M. Sylvain CPA Executive VP, CFO & Chief Accounting Officer 1980
Mr. Michael Jon Brown J.D. Executive VP, Chief Legal & Compliance Officer 1970
Ms. Sadie M. Stern Executive VP, Chief People & Culture Officer 1975
Mr. Jon Coleman Executive VP & Chief Commercial Officer 1964
Mr. Peter Simpson Executive VP & CTO NA
Mr. Sean Christensen Vice President of Finance and Investor Relations NA
Mr. Matthew Dolan Executive Vice President of Strategy & Corporate Development 1981

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 15, 2026 Michael Jon Brown N/A Sale 1.70K $63.04 $107.17K
Mar 30, 2026 Ro Khanna N/A Sale N/A $61.90 N/A
Mar 23, 2026 Ro Khanna N/A Sale N/A $65.94 N/A
Mar 16, 2026 Michael Jon Brown N/A Sale 1.70K $64.85 $110.25K
Feb 17, 2026 Ro Khanna N/A Purchase N/A $70.43 N/A
Feb 05, 2026 Ro Khanna N/A Sale N/A $69.89 N/A
Feb 04, 2026 Michael T. McCaul N/A Sale N/A $70.83 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $74.00 N/A
Jan 26, 2026 John Boozman N/A Purchase N/A $73.34 N/A
Nov 14, 2025 Richard Alexander Collins N/A Sale 2.91K $59.05 $171.60K
Nov 12, 2025 Bridgette P Heller N/A Sale 1.01K $58.07 $58.77K
Nov 10, 2025 Jacob Steven Leach N/A Purchase 18.20K $55.04 $1.00M
Nov 10, 2025 Richard Alexander Collins N/A Sale 3.95K $55.17 $217.81K
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $70.63 N/A
Sep 29, 2025 Ro Khanna N/A Sale N/A $66.46 N/A
Sep 22, 2025 Michael T. McCaul N/A Purchase N/A $69.51 N/A
Sep 05, 2025 Kyle Malady N/A Sale 667.00 $80.86 $53.93K
Sep 04, 2025 Sadie Stern N/A Sale 1.47K $80.00 $117.28K
Aug 21, 2025 Michael T. McCaul N/A Sale N/A $80.62 N/A
Aug 15, 2025 Michael Jon Brown N/A Sale 500.00 $80.29 $40.15K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 49.07M Dec 31, 2025 12.72% $0.05 -0.77%
BlackRock Inc 38.96M Mar 31, 2026 10.10% $0.04 -2.22%
Vanguard Capital Management, LLC 25.02M Mar 31, 2026 6.48% $0.04 0.00%
Vanguard Portfolio Management, LLC 19.22M Mar 31, 2026 4.98% $0.06 0.00%
State Street Corp 17.93M Mar 31, 2026 4.65% $0.04 -0.88%
Baillie Gifford & Co Limited. 15.60M Mar 31, 2026 4.04% $1.00 0.30%
Amvescap Plc. 13.67M Mar 31, 2026 3.54% $0.08 -2.88%
AllianceBernstein L.P. 12.92M Mar 31, 2026 3.35% $0.28 49.85%
Geode Capital Management, LLC 12.35M Mar 31, 2026 3.20% $0.05 12.18%
UBS Asset Mgmt Americas Inc 9.75M Mar 31, 2026 2.53% $0.13 21.84%
Wellington Management Company LLP 9.33M Mar 31, 2026 2.42% $0.11 203.43%
NORGES BANK 7.28M Dec 31, 2025 1.89% $0.05 40.25%
Amundi 6.33M Mar 31, 2026 1.64% $0.11 28.77%
JPMorgan Chase & Co 6.00M Mar 31, 2026 1.55% $0.02 -3.49%
Morgan Stanley - Brokerage Accounts 5.04M Mar 31, 2026 1.31% $0.02 -0.60%
UBS Group AG 4.35M Mar 31, 2026 1.13% $0.04 126.12%
Ameriprise Financial Inc 4.24M Mar 31, 2026 1.10% $0.06 99.26%
CIBC Bancorp USA Inc. 4.22M Mar 31, 2026 1.09% $0.36 6,060.00%
Northern Trust Corp 3.43M Mar 31, 2026 0.89% $0.03 1.44%
Deutsche Bank AG 3.39M Mar 31, 2026 0.88% $0.07 -21.63%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 12.25M 3.18% ▲ 0.01% Jun 30, 2026
2 Vanguard 500 Index Investor 10.02M 2.60% ▼ 0.50% Jun 30, 2026
3 Vanguard Mid Cap Index Institutional 8.36M 2.17% ▲ 0.15% Jun 30, 2026
4 Invesco QQQ Trust 8.19M 2.12% ▼ 0.77% Jun 30, 2026
5 Vanguard Health Care Inv 6.06M 1.57% ▲ 0.00% Mar 31, 2026
6 UBS: Global Equity 5.51M 1.43% ▲ 31.93% Mar 31, 2026
7 iShares Core S&P 500 ETF 5.33M 1.38% ▲ 0.32% Jun 30, 2026
8 Vanguard Growth Index Investor 4.94M 1.28% ▲ 1.12% Jun 30, 2026
9 Fidelity 500 Index 4.93M 1.28% ▼ 0.14% May 31, 2026
10 State Street® SPDR® S&P 500® ETF 4.65M 1.20% ▼ 1.29% Jun 30, 2026

Financial Highlights

Market Cap: $28.31B
EBITDA: $1.29B
P/E Ratio: $31.49
PEG Ratio: $1.33
Book Value: $7.66
Earnings/Share: $2.33
Profit Margin: 19.31%
Operating Margin: 21.42%
ROA (TTM): 9.65%
ROE (TTM): 35.62%
Revenue (TTM): $4.82B
Revenue/Share (TTM): $12.40
Earnings Growth (YOY): 92.20%
Revenue Growth (YOY): 15.00%

Valuation Metrics

Enterprise Value: $26.57B
Trailing P/E: 31.49
Forward P/E: 27.93

Shares Statistics

Shares Outstanding: 385.87M
Shares Float: 384.56M
% Insiders: 26.40%
% Institutions: 10,440.80%
Short % Float: 5.56%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$4.66B
Cost of Goods Sold
adjust
$-1.86B
Gross Profit
subtotal
$2.80B
SG&A
adjust
$-1.29B
R&D
adjust
$-594.90M
Operating Income
subtotal
$911.80M
Other / Non-Operating Items
adjust
$-75.50M
Net Income
subtotal
$836.30M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DXCM.US!